Antia Figueroa-Romero
Overview
Explore the profile of Antia Figueroa-Romero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atchade A, Yadouleton A, Fiogbe M, Abdoulaye Alfa D, Yovo E, Le Hesran J, et al.
PLOS Glob Public Health
. 2025 Feb;
5(2):e0004227.
PMID: 39946403
NCT06170320 (retrospectively registered on December 21, 2023).
2.
Mendes-Muxlhanga A, Nhacolo A, Figueroa-Romero A, Mazuze M, Mayor A, Vala A, et al.
BMC Public Health
. 2025 Jan;
25(1):251.
PMID: 39838327
Background: Monitoring HIV infection estimates is critical to guide health interventions and assess their impact, especially in highly vulnerable groups to the infection such as African pregnant women. This study...
3.
Gonzalez R, Nhampossa T, Figueroa-Romero A, Tchouatieu A, Manyando C, Menendez C
PLoS Med
. 2024 Dec;
21(12):e1004498.
PMID: 39656683
Raquel González and colleagues discuss the drugs available to HIV-exposed children to prevent malaria infection and the urgent need to evaluate alternative agents.
4.
Owusu-Kyei K, Chen H, Chileshe M, Quinto L, Sibley M, Figueroa-Romero A, et al.
Trials
. 2024 Sep;
25(1):626.
PMID: 39334260
Background: Azithromycin has been shown to be beneficial in preventing infectious diseases, including malaria, infectious diarrhoea and pneumonia. A cluster randomised control trial on azithromycin MDA in children in Niger,...
5.
Figueroa-Romero A, Atchade A, Yadouleton A, Fiogbe M, Bonnet E, Yovo E, et al.
BMC Public Health
. 2024 Jul;
24(1):1762.
PMID: 38956517
Background: Pregnant women are a vulnerable population to COVID-19 given an increased susceptibility to severe SARS-CoV-2 infection and pregnancy complications. However, few SARS-CoV-2 serological surveys have been performed among this...
6.
Figueroa-Romero A, Saura-Lazaro A, Fernandez-Luis S, Gonzalez R
Lancet HIV
. 2024 Mar;
11(4):e255-e267.
PMID: 38458223
The geographical distribution of malaria and HIV infections widely overlap in sub-Saharan Africa, constituting a complex global health challenge. The interplay between both infections raises concerns about potential immunological, clinical,...
7.
Gonzalez R, Nhampossa T, Mombo-Ngoma G, Mischlinger J, Esen M, Tchouatieu A, et al.
Lancet Infect Dis
. 2024 Jan;
24(5):476-487.
PMID: 38224706
Background: The cornerstone of malaria prevention in pregnancy, intermittent preventive treatment (IPTp) with sulfadoxine-pyrimethamine, is contraindicated in women with HIV who are receiving co-trimoxazole prophylaxis. We assessed whether IPTp with...
8.
Arikawa S, Tchankoni M, Gbeasor-Komlanvi F, Atekpe S, Atcha-Oubou T, Figueroa-Romero A, et al.
Malar J
. 2023 Nov;
22(1):357.
PMID: 37990324
Background: Malaria remains the leading cause of mortality and morbidity in young children in sub-Saharan Africa. To prevent malaria in children living in moderate-to-high malaria transmission areas, the World Health...
9.
Figueroa-Romero A, Bissombolo D, Meremikwu M, Ratsimbasoa A, Sacoor C, Arikpo I, et al.
Lancet Glob Health
. 2023 Oct;
11(11):e1765-e1774.
PMID: 37858587
Background: The effectiveness of community delivery of intermittent preventive treatment (C-IPT) of malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine has been evaluated in selected areas of the Democratic Republic of the...
10.
Fuente-Soro L, Figueroa-Romero A, Fernandez-Luis S, Augusto O, Lopez-Varela E, Bernardo E, et al.
BMC Health Serv Res
. 2023 Aug;
23(1):925.
PMID: 37649011
Background: Non-disclosure of known HIV status by people living with HIV but undergoing HIV testing leads to waste of HIV testing resources and distortion of estimates of HIV indicators. In...